Topical Oxybutynin for Treatment of Hyperidrosis: a Local or a Systemic Effect?

• Status: Not yet recruiting
• Trial end date: 2022-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The TODAY trial is a study to evaluate the efficacy and safety of topical oxybutynin deodorant for use in patients with axillary hyperhidrosis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Samantha Rodrigues Camargo Neves de Moura
• Collaborator: Science Valley Research Institute
• Treatments: Mandelic Acids; Oxybutynin

Criteria

Inclusion Criteria:

• Patients with a clinical diagnosis of axillary hyperhidrosis.

• Patients aged between 18 and 45 years old.

• Patients who are not being treated with another drug or treatment methodology for the disease.

• Patients who sign the consent form.

Exclusion Criteria:

• Patients who are hypersensitive to oxybutynin hydrochloride.

• Patients diagnosed with glaucoma, total and partial obstruction of the intestinal tract, ulcerative colitis, megacolon and myasthenia gravis and cardiac diseases.

• Patients who are pregnant or intend to become pregnant.

• Patients who have previous indications for treatment with OX.